PolyPid Historical Financial Ratios

PYPD Stock

USD 2.81 0.04 1.40%

PolyPid is promptly reporting on over 93 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Stock Based Compensation To Revenue of 0.0, Capex To Depreciation of 0.0445, EV To Sales of 0.0 or Inventory Turnover of 7.64 will help investors to properly organize and evaluate PolyPid financial condition quickly.

Quick Ratio Current Ratio

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PolyPid. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

For information on how to trade PolyPid Stock refer to our How to Trade PolyPid Stock guide.

About PolyPid Financial Ratios Analysis

PolyPidFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate PolyPid investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on PolyPid financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across PolyPid history.

PolyPid Financial Ratios Chart

At present, PolyPid's Days Of Inventory On Hand is projected to decrease significantly based on the last few years of reporting. The current year's EV To Operating Cash Flow is expected to grow to 0.29, whereas Book Value Per Share is forecasted to decline to (1.41).

Cash Per Share Days Payables Outstanding Current Ratio Capex Per Share

Add Fundamental

Current Ratio

A liquidity ratio that measures a company's ability to pay short-term obligations or those due within one year. It compares a firm's current assets to its current liabilities.

Most ratios from PolyPid's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into PolyPid current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PolyPid. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

For information on how to trade PolyPid Stock refer to our How to Trade PolyPid Stock guide.At present, PolyPid's Days Of Inventory On Hand is projected to decrease significantly based on the last few years of reporting. The current year's EV To Operating Cash Flow is expected to grow to 0.29, whereas Book Value Per Share is forecasted to decline to (1.41).

PolyPid fundamentals Correlations

	Ptb Ratio	Book Value Per Share	Free Cash Flow Yield	Operating Cash Flow Per Share	Capex To Depreciation	Pb Ratio	Free Cash Flow Per Share	Inventory Turnover	Net Income Per Share	Days Of Inventory On Hand	Cash Per Share	Pocfratio	Interest Coverage	Capex To Operating Cash Flow	Pfcf Ratio	Days Payables Outstanding	Income Quality	Ev To Operating Cash Flow	Pe Ratio	Ev To Free Cash Flow	Net Debt To E B I T D A	Current Ratio	Tangible Book Value Per Share	Shareholders Equity Per Share	Debt To Equity	Capex Per Share
Ptb Ratio		-0.1	-0.23	-0.33	0.42	1.0	-0.34	0.36	-0.16	-0.1	0.33	0.06	-0.2	-0.31	0.08	-0.26	-0.03	0.06	0.08	0.08	0.02	0.33	-0.1	-0.1	0.26	0.29
Book Value Per Share	-0.1		-0.15	0.11	-0.82	-0.1	0.17	0.5	0.49	-0.2	-0.08	-0.05	-0.38	0.62	-0.05	-0.61	0.55	-0.05	-0.1	-0.05	-0.16	0.2	1.0	1.0	-0.16	-0.59
Free Cash Flow Yield	-0.23	-0.15		0.14	0.36	-0.23	0.09	-0.74	0.07	-0.12	0.31	-0.42	-0.22	-0.51	-0.43	0.66	-0.02	-0.42	-0.27	-0.43	0.79	0.45	-0.15	-0.15	0.25	0.3
Operating Cash Flow Per Share	-0.33	0.11	0.14		-0.31	-0.33	1.0	-0.54	0.49	0.4	-0.66	-0.8	0.29	0.27	-0.81	0.31	0.15	-0.8	-0.79	-0.81	0.26	-0.12	0.11	0.11	-0.65	-0.69
Capex To Depreciation	0.42	-0.82	0.36	-0.31		0.42	-0.38	-0.41	-0.46	-0.07	0.42	-0.02	0.02	-0.92	-0.01	0.51	-0.52	-0.02	0.07	-0.01	0.34	0.2	-0.82	-0.82	0.43	0.83
Pb Ratio	1.0	-0.1	-0.23	-0.33	0.42		-0.34	0.36	-0.16	-0.1	0.33	0.06	-0.2	-0.31	0.08	-0.26	-0.03	0.06	0.08	0.08	0.02	0.33	-0.1	-0.1	0.26	0.29
Free Cash Flow Per Share	-0.34	0.17	0.09	1.0	-0.38	-0.34		-0.48	0.5	0.41	-0.67	-0.78	0.28	0.35	-0.79	0.26	0.21	-0.78	-0.77	-0.79	0.23	-0.12	0.17	0.17	-0.66	-0.75
Inventory Turnover	0.36	0.5	-0.74	-0.54	-0.41	0.36	-0.48		-0.1	-0.14	0.16	0.6	-0.29	0.43	0.61	-0.86	0.26	0.6	0.49	0.6	-0.68	-0.04	0.5	0.5	0.08	-0.1
Net Income Per Share	-0.16	0.49	0.07	0.49	-0.46	-0.16	0.5	-0.1		0.17	-0.48	-0.39	-0.13	0.24	-0.39	-0.35	0.01	-0.39	-0.22	-0.39	0.2	-0.06	0.49	0.49	-0.29	-0.47
Days Of Inventory On Hand	-0.1	-0.2	-0.12	0.4	-0.07	-0.1	0.41	-0.14	0.17		-0.26	-0.16	-0.13	0.18	-0.17	-0.02	-0.02	-0.16	-0.09	-0.17	-0.01	0.05	-0.2	-0.2	-0.21	-0.35
Cash Per Share	0.33	-0.08	0.31	-0.66	0.42	0.33	-0.67	0.16	-0.48	-0.26		0.45	-0.61	-0.33	0.46	0.09	0.14	0.46	0.48	0.46	0.32	0.76	-0.08	-0.08	0.63	0.54
Pocfratio	0.06	-0.05	-0.42	-0.8	-0.02	0.06	-0.78	0.6	-0.39	-0.16	0.45		-0.25	0.15	1.0	-0.44	-0.18	1.0	0.94	1.0	-0.52	-0.06	-0.05	-0.05	0.35	0.37
Interest Coverage	-0.2	-0.38	-0.22	0.29	0.02	-0.2	0.28	-0.29	-0.13	-0.13	-0.61	-0.25		0.1	-0.25	0.38	-0.1	-0.25	-0.39	-0.25	-0.1	-0.75	-0.38	-0.38	-0.38	-0.16
Capex To Operating Cash Flow	-0.31	0.62	-0.51	0.27	-0.92	-0.31	0.35	0.43	0.24	0.18	-0.33	0.15	0.1		0.13	-0.42	0.58	0.14	-0.01	0.13	-0.34	-0.18	0.62	0.62	-0.42	-0.85
Pfcf Ratio	0.08	-0.05	-0.43	-0.81	-0.01	0.08	-0.79	0.61	-0.39	-0.17	0.46	1.0	-0.25	0.13		-0.45	-0.19	1.0	0.94	1.0	-0.52	-0.06	-0.05	-0.05	0.35	0.38
Days Payables Outstanding	-0.26	-0.61	0.66	0.31	0.51	-0.26	0.26	-0.86	-0.35	-0.02	0.09	-0.44	0.38	-0.42	-0.45		-0.02	-0.44	-0.41	-0.45	0.63	0.07	-0.61	-0.61	0.02	0.21
Income Quality	-0.03	0.55	-0.02	0.15	-0.52	-0.03	0.21	0.26	0.01	-0.02	0.14	-0.18	-0.1	0.58	-0.19	-0.02		-0.18	-0.24	-0.19	0.24	0.29	0.55	0.55	-0.14	-0.58
Ev To Operating Cash Flow	0.06	-0.05	-0.42	-0.8	-0.02	0.06	-0.78	0.6	-0.39	-0.16	0.46	1.0	-0.25	0.14	1.0	-0.44	-0.18		0.94	1.0	-0.52	-0.06	-0.05	-0.05	0.35	0.37
Pe Ratio	0.08	-0.1	-0.27	-0.79	0.07	0.08	-0.77	0.49	-0.22	-0.09	0.48	0.94	-0.39	-0.01	0.94	-0.41	-0.24	0.94		0.94	-0.37	0.0	-0.1	-0.1	0.41	0.47
Ev To Free Cash Flow	0.08	-0.05	-0.43	-0.81	-0.01	0.08	-0.79	0.6	-0.39	-0.17	0.46	1.0	-0.25	0.13	1.0	-0.45	-0.19	1.0	0.94		-0.52	-0.06	-0.05	-0.05	0.36	0.38
Net Debt To E B I T D A	0.02	-0.16	0.79	0.26	0.34	0.02	0.23	-0.68	0.2	-0.01	0.32	-0.52	-0.1	-0.34	-0.52	0.63	0.24	-0.52	-0.37	-0.52		0.55	-0.16	-0.16	0.18	0.06
Current Ratio	0.33	0.2	0.45	-0.12	0.2	0.33	-0.12	-0.04	-0.06	0.05	0.76	-0.06	-0.75	-0.18	-0.06	0.07	0.29	-0.06	0.0	-0.06	0.55		0.2	0.2	0.41	0.1
Tangible Book Value Per Share	-0.1	1.0	-0.15	0.11	-0.82	-0.1	0.17	0.5	0.49	-0.2	-0.08	-0.05	-0.38	0.62	-0.05	-0.61	0.55	-0.05	-0.1	-0.05	-0.16	0.2		1.0	-0.16	-0.59
Shareholders Equity Per Share	-0.1	1.0	-0.15	0.11	-0.82	-0.1	0.17	0.5	0.49	-0.2	-0.08	-0.05	-0.38	0.62	-0.05	-0.61	0.55	-0.05	-0.1	-0.05	-0.16	0.2	1.0		-0.16	-0.59
Debt To Equity	0.26	-0.16	0.25	-0.65	0.43	0.26	-0.66	0.08	-0.29	-0.21	0.63	0.35	-0.38	-0.42	0.35	0.02	-0.14	0.35	0.41	0.36	0.18	0.41	-0.16	-0.16		0.59
Capex Per Share	0.29	-0.59	0.3	-0.69	0.83	0.29	-0.75	-0.1	-0.47	-0.35	0.54	0.37	-0.16	-0.85	0.38	0.21	-0.58	0.37	0.47	0.38	0.06	0.1	-0.59	-0.59	0.59

Click cells to compare fundamentals

PolyPid Account Relationship Matchups

PolyPid fundamentals Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Ptb Ratio	5.21	5.93	4.63	(2.55)	(2.29)	(2.41)
Book Value Per Share	56.96	29.03	4.53	(1.49)	(1.34)	(1.41)
Free Cash Flow Yield	(0.06)	(0.16)	(1.33)	(3.27)	(3.76)	(3.57)
Operating Cash Flow Per Share	(16.9)	(25.95)	(26.5)	(12.27)	(14.11)	(14.82)
Capex To Depreciation	1.16	2.68	1.03	0.11	0.0469	0.0445
Pb Ratio	5.21	5.93	4.63	(2.55)	(2.29)	(2.41)
Free Cash Flow Per Share	(17.82)	(28.35)	(27.86)	(12.41)	(14.27)	(14.99)
Inventory Turnover	2.7	1.57	(0.0497)	8.08	7.27	7.64
Net Income Per Share	(27.65)	(32.62)	(30.52)	(16.99)	(19.54)	(20.52)
Days Of Inventory On Hand	135.29	232.99	(7.3K)	45.17	51.95	54.55
Cash Per Share	34.81	25.8	9.72	3.99	3.59	3.41
Pocfratio	(17.57)	(6.64)	(0.79)	(0.31)	(0.28)	(0.29)
Interest Coverage	(1.2K)	(1.5K)	(38.01)	(13.36)	(15.37)	(16.14)
Capex To Operating Cash Flow	(0.0545)	(0.0924)	(0.0515)	(0.0114)	(0.00346)	(0.003633)
Pfcf Ratio	(16.66)	(6.07)	(0.75)	(0.31)	(0.28)	(0.29)
Days Payables Outstanding	351.29	1.4K	241.99	154.65	177.85	168.96
Income Quality	2.51	0.59	0.76	0.87	0.72	0.46
Ev To Operating Cash Flow	(17.37)	(6.33)	(0.94)	(0.67)	0.27	0.29
Pe Ratio	(10.74)	(5.28)	(0.69)	(0.22)	(0.2)	(0.21)
Ev To Free Cash Flow	(16.47)	(5.8)	(0.9)	(0.66)	0.27	0.29
Net Debt To E B I T D A	0.12	0.24	(0.14)	(0.3)	(0.35)	(0.33)
Current Ratio	16.54	4.46	1.64	0.83	1.31	1.24
Tangible Book Value Per Share	56.96	29.03	4.53	(1.49)	(1.34)	(1.41)
Shareholders Equity Per Share	56.96	29.03	4.53	(1.49)	(1.34)	(1.41)
Graham Net Net	32.51	10.37	(5.84)	(8.44)	(7.6)	(7.98)
Interest Debt Per Share	0.0169	0.0133	11.39	9.61	11.05	12.46
Enterprise Value Over E B I T D A	(10.46)	(4.94)	(0.89)	(0.57)	(0.51)	(0.54)
Roic	(0.34)	(1.13)	(1.68)	(1.82)	(1.63)	(1.72)
Payables Turnover	1.04	0.27	1.51	2.36	2.12	2.23
Roe	(0.49)	(1.12)	(6.74)	11.39	13.09	13.75
Return On Tangible Assets	(0.47)	(0.92)	(1.52)	(1.55)	(1.4)	(1.47)
Earnings Yield	(0.0931)	(0.19)	(1.46)	(4.47)	(5.14)	(4.89)
Price Earnings Ratio	(10.74)	(5.28)	(0.69)	(0.22)	(0.2)	(0.21)
Operating Cycle	135.29	232.99	(7.3K)	45.17	51.95	54.55
Price Book Value Ratio	5.21	5.93	4.63	(2.55)	(2.29)	(2.41)
Price Earnings To Growth Ratio	0.009493	0.13	0.11	0.002598	0.002338	0.002455
Days Of Payables Outstanding	351.29	1.4K	241.99	154.65	177.85	168.96

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria

When determining whether PolyPid is a strong investment it is important to analyze PolyPid's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact PolyPid's future performance. For an informed investment choice regarding PolyPid Stock, refer to the following important reports:

How To Invest In PolyPid

Details

Is PolyPid Stock a good investment?

Details

What is PolyPid's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

For information on how to trade PolyPid Stock refer to our How to Trade PolyPid Stock guide.

You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PolyPid. If investors know PolyPid will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PolyPid listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(4.91)

Return On Assets

(0.86)

Return On Equity

(10.39)

The market value of PolyPid is measured differently than its book value, which is the value of PolyPid that is recorded on the company's balance sheet. Investors also form their own opinion of PolyPid's value that differs from its market value or its book value, called intrinsic value, which is PolyPid's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PolyPid's market value can be influenced by many factors that don't directly affect PolyPid's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between PolyPid's value and its price as these two are different measures arrived at by different means. Investors typically determine if PolyPid is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PolyPid's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Price To Sales Ratio	Ptb Ratio
Days Sales Outstanding	Book Value Per Share
Free Cash Flow Yield	Invested Capital
Operating Cash Flow Per Share	Average Payables
Stock Based Compensation To Revenue	Capex To Depreciation
Pb Ratio	Ev To Sales
Free Cash Flow Per Share	Inventory Turnover
Net Income Per Share	Days Of Inventory On Hand
Sales General And Administrative To Revenue	Average Inventory
Research And Ddevelopement To Revenue	Capex To Revenue
Cash Per Share	Pocfratio
Interest Coverage	Payout Ratio
Capex To Operating Cash Flow	Pfcf Ratio
Days Payables Outstanding	Net Current Asset Value
Income Quality	Tangible Asset Value
Ev To Operating Cash Flow	Pe Ratio
Ev To Free Cash Flow	Intangibles To Total Assets
Net Debt To E B I T D A	Current Ratio
Tangible Book Value Per Share	Receivables Turnover
Shareholders Equity Per Share	Debt To Equity
Capex Per Share	Graham Net Net
Average Receivables	Revenue Per Share
Interest Debt Per Share	Debt To Assets
Enterprise Value Over E B I T D A	Dividend Yield
Roic	Payables Turnover
Roe	Return On Tangible Assets
Earnings Yield	Graham Number
Short Term Coverage Ratios	Price Earnings Ratio
Operating Cycle	Price Book Value Ratio
Price Earnings To Growth Ratio	Days Of Payables Outstanding
Dividend Payout Ratio	Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio	Pretax Profit Margin
Ebt Per Ebit	Operating Profit Margin
Effective Tax Rate	Company Equity Multiplier
Long Term Debt To Capitalization	Total Debt To Capitalization
Debt Equity Ratio	Ebit Per Revenue
Quick Ratio	Dividend Paid And Capex Coverage Ratio
Net Income Per E B T	Cash Ratio
Cash Conversion Cycle	Operating Cash Flow Sales Ratio
Days Of Inventory Outstanding	Days Of Sales Outstanding
Free Cash Flow Operating Cash Flow Ratio	Cash Flow Coverage Ratios
Price To Book Ratio	Capital Expenditure Coverage Ratio
Price Cash Flow Ratio	Enterprise Value Multiple
Debt Ratio	Cash Flow To Debt Ratio
Price Sales Ratio	Net Profit Margin
Gross Profit Margin	Price Fair Value
Return On Capital Employed	Fixed Asset Turnover
Return On Assets	Asset Turnover
Return On Equity

PolyPid Historical Financial Ratios

About PolyPid Financial Ratios Analysis

PolyPid Financial Ratios Chart

Current Ratio

PolyPid fundamentals Correlations

PolyPid Account Relationship Matchups

High Positive Relationship

High Negative Relationship

PolyPid fundamentals Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Pb Ratio	+ 1.0	Ptb Ratio
Tangible Book Value Per Share	+ 1.0	Book Value Per Share
Shareholders Equity Per Share	+ 1.0	Book Value Per Share
Free Cash Flow Per Share	+ 1.0	Operating Cash Flow Per Share
Pfcf Ratio	+ 1.0	Pocfratio
Ev To Operating Cash Flow	+ 1.0	Pocfratio

Capex To Operating Cash Flow	- 0.92	Capex To Depreciation
Days Payables Outstanding	- 0.86	Inventory Turnover
Capex Per Share	- 0.85	Capex To Operating Cash Flow
Shareholders Equity Per Share	- 0.82	Capex To Depreciation
Tangible Book Value Per Share	- 0.82	Capex To Depreciation
Capex To Depreciation	- 0.82	Book Value Per Share